← Back to Search

Strategy Training for Stroke Survivors

N/A
Waitlist Available
Led By Naor Domotor, PhD
Research Sponsored by University of Haifa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Primary diagnosis of acute stroke
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will provide strategy training to adult stroke survivors living in the community. The study aims to see if having a pet helps improve their thinking skills and participation in community activities. Strategy training teaches new ways to think and solve problems, which can help with daily tasks.

Who is the study for?
This trial is for adult stroke survivors who are at least 3 months post-stroke, experiencing reduced activity levels and some cognitive impairment. Participants must live with a pet, be willing to undergo a 6-week home-based program with two sessions weekly, and have had a primary diagnosis of acute stroke.
What is being tested?
The study is testing 'strategy training' to see if it helps improve cognitive performance and community involvement in stroke survivors. It will also explore whether having pets affects the outcomes of this intervention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with an acute stroke.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mean engagement score as measured by the Pittsburgh Rehabilitation Participation Scale
Secondary study objectives
Change in attention as measured by the Color Trail Test 1
Change in community participation as measure by Community Participation Indicators score
Change in executive function as measured by the Color Trail Test 2

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Stroke survivors with petsExperimental Treatment1 Intervention
Stroke survivors with pets will receive strategy training for 10-15 sessions, 45 minutes each session, delivered by a trained occupational therapist in the home.
Group II: Stroke survivors without petsActive Control1 Intervention
Stroke survivors without pets will receive strategy training for 10-15 sessions, 45 minutes each session, delivered by a trained occupational therapist in the home.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Strategy Training
2013
N/A
~180

Find a Location

Who is running the clinical trial?

University of HaifaLead Sponsor
123 Previous Clinical Trials
22,056 Total Patients Enrolled
7 Trials studying Stroke
617 Patients Enrolled for Stroke
University of PittsburghLead Sponsor
1,789 Previous Clinical Trials
16,359,573 Total Patients Enrolled
28 Trials studying Stroke
2,851 Patients Enrolled for Stroke
Naor Domotor, PhDPrincipal InvestigatorUniversity of Pittsburgh
~33 spots leftby Dec 2025